Where could gammadelta T cells take us in the treatment of cancer?

Expert Opin Biol Ther. 2023 Jan;23(1):1-5. doi: 10.1080/14712598.2022.2147424. Epub 2022 Nov 21.

Authors

Anna Maria Corsale^{1

2}, Marta Di Simone^{1

2}, Francesco Dieli^{1

2}, Serena Meraviglia^{1

2}

Affiliations

¹ Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, 90129, Palermo, Italy.
² Department of Biomedicine, Neurosciences and Advanced Diagnosis, University of Palermo, 90129, Palermo, Italy.

PMID: 36374510
DOI: 10.1080/14712598.2022.2147424

No abstract available

Keywords: Adoptive cell therapy; CAR-T cells; allogeneic cells; bisphosphonates; cancer immunotherapy; phosphoantigens; γδ T cells.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunotherapy, Adoptive
Lymphocyte Activation
Neoplasms* / therapy
T-Lymphocytes